Trial Site Detail

 

Drug:
Imatinib
Trial:
A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing c-Kit Gene (Extension of US Phase II study, B2222)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Knight Cancer Institute at Oregon Health Sciences University (OHSU)

3181 S.W. Sam Jackson Park Rd.     
Portland , OR 97239
USA

 

Principal Investigator:
Contact:
Activation Status of this Site:
Closed
Notes about this Site:
Knight Cancer Institute at Oregon Health Sciences University (OHSU) Website:
http://www.ohsu.edu/isr/trial_search1.cfm

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.